214 related articles for article (PubMed ID: 20105289)
1. Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat.
Vahtola E; Louhelainen M; Forstén H; Merasto S; Raivio J; Kaheinen P; Kytö V; Tikkanen I; Levijoki J; Mervaala E
Cardiovasc Diabetol; 2010 Jan; 9():5. PubMed ID: 20105289
[TBL] [Abstract][Full Text] [Related]
2. Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat.
Vahtola E; Louhelainen M; Merasto S; Martonen E; Penttinen S; Aahos I; Kytö V; Virtanen I; Mervaala E
J Hypertens; 2008 Feb; 26(2):334-44. PubMed ID: 18192848
[TBL] [Abstract][Full Text] [Related]
3. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
4. Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity.
Samuel SM; Thirunavukkarasu M; Penumathsa SV; Paul D; Maulik N
J Agric Food Chem; 2008 Oct; 56(20):9692-8. PubMed ID: 18826227
[TBL] [Abstract][Full Text] [Related]
5. Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
Vahtola E; Storvik M; Louhelainen M; Merasto S; Lakkisto P; Lakkisto J; Tikkanen I; Kaheinen P; Levijoki J; Mervaala E
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):387-97. PubMed ID: 21699655
[TBL] [Abstract][Full Text] [Related]
6. Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1/FoxO3a pathway.
Chen L; Li S; Zhu J; You A; Huang X; Yi X; Xue M
J Cell Mol Med; 2021 Mar; 25(6):2944-2955. PubMed ID: 33523605
[TBL] [Abstract][Full Text] [Related]
7. Effects of the calcium sensitizer OR-1896, a metabolite of levosimendan, on post-infarct heart failure and cardiac remodelling in diabetic Goto-Kakizaki rats.
Louhelainen M; Merasto S; Finckenberg P; Vahtola E; Kaheinen P; Levijoki J; Mervaala E
Br J Pharmacol; 2010 May; 160(1):142-52. PubMed ID: 20412071
[TBL] [Abstract][Full Text] [Related]
8. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
9. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.
Bäcklund T; Palojoki E; Saraste A; Eriksson A; Finckenberg P; Kytö V; Lakkisto P; Mervaala E; Voipio-Pulkki LM; Laine M; Tikkanen I
Diabetologia; 2004 Feb; 47(2):325-30. PubMed ID: 14722653
[TBL] [Abstract][Full Text] [Related]
10. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.
Ding M; Lei J; Han H; Li W; Qu Y; Fu E; Fu F; Wang X
Cardiovasc Diabetol; 2015 Oct; 14():143. PubMed ID: 26489513
[TBL] [Abstract][Full Text] [Related]
12. IL-17A promotes ventricular remodeling after myocardial infarction.
Zhou SF; Yuan J; Liao MY; Xia N; Tang TT; Li JJ; Jiao J; Dong WY; Nie SF; Zhu ZF; Zhang WC; Lv BJ; Xiao H; Wang Q; Tu X; Liao YH; Shi GP; Cheng X
J Mol Med (Berl); 2014 Oct; 92(10):1105-16. PubMed ID: 24965614
[TBL] [Abstract][Full Text] [Related]
13. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2.
Pan Z; Zhao W; Zhang X; Wang B; Wang J; Sun X; Liu X; Feng S; Yang B; Lu Y
Br J Pharmacol; 2011 Feb; 162(3):688-700. PubMed ID: 20942814
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 Ameliorates Cardiac Remodeling in Experimentally Induced Myocardial Infarction in Rats by Inhibiting PARP1/NF-κB Axis in A SIRT1-Dependent Mechanism.
Eid RA; Alharbi SA; El-Kott AF; Eleawa SM; Zaki MSA; El-Sayed F; Eldeen MA; Aldera H; Al-Shudiefat AAS
Cardiovasc Toxicol; 2020 Aug; 20(4):401-418. PubMed ID: 32193876
[TBL] [Abstract][Full Text] [Related]
15. Lingbao Huxin Pill Alleviates Apoptosis and Inflammation at Infarct Border Zone through SIRT1-Mediated FOXO1 and NF- κ B Pathways in Rat Model of Acute Myocardial Infarction.
Tan Y; Bie YL; Chen L; Zhao YH; Song L; Miao LN; Yu YQ; Chai H; Ma XJ; Shi DZ
Chin J Integr Med; 2022 Apr; 28(4):330-338. PubMed ID: 34826042
[TBL] [Abstract][Full Text] [Related]
16. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
[TBL] [Abstract][Full Text] [Related]
17. Mild type 2 diabetes mellitus improves remote endothelial dysfunction after acute myocardial infarction.
Korkmaz-Icöz S; Vater A; Li S; Lehner A; Radovits T; Hegedűs P; Ruppert M; Brlecic P; Zorn M; Karck M; Szabó G
J Diabetes Complications; 2015; 29(8):1253-60. PubMed ID: 26219999
[TBL] [Abstract][Full Text] [Related]
18. Lin28a protects against postinfarction myocardial remodeling and dysfunction through Sirt1 activation and autophagy enhancement.
Hao Y; Lu Q; Yang G; Ma A
Biochem Biophys Res Commun; 2016 Oct; 479(4):833-840. PubMed ID: 27693787
[TBL] [Abstract][Full Text] [Related]
19. The Goto Kakizaki rat: Impact of age upon changes in cardiac and renal structure, function.
Meagher P; Civitarese R; Lee X; Gordon M; Bugyei-Twum A; Desjardins JF; Kabir G; Zhang Y; Kosanam H; Visram A; Leong-Poi H; Advani A; Connelly KA
PLoS One; 2021; 16(6):e0252711. PubMed ID: 34166385
[TBL] [Abstract][Full Text] [Related]
20. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
